Leukemia Research
Volume 30, Issue 4 , Pages 469-476 , April 2006

Sorcin, an important gene associated with multidrug-resistance in human leukemia cells

Received 21 July 2005 ,Revised 22 August 2005 ,Accepted 23 August 2005.

References 

  1. Suarez L, Vidriales MB, Moreno MJ, Lopez A, Garcia-Larana J, Perez-Lopez C, et al. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells. Haematologica. 2005;90:54–59
  2. Hirose M, Hosoi E, Hamano S, Jalili A. Multidrug resistance in hematological malignancy. J Med Invest. 2003;50:126–135
  3. Ivy SP, Olshefski RS, Taylor BJ, Patel KM, Reaman GH. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study. Blood. 1996;88:309–318
  4. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem. 2002;71:537–592
  5. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48–58
  6. Filipits M, Stranzl T, Pohl G, Heinzl H, Jager U, Geissler K, et al. Drug resistance factors in acute myeloid leukemia: a comparative analysis. Leukemia. 2000;14:68–76
  7. Yang CZ, Luan FJ, Xiong DS, Liu BR, Xu YF, Gu KS. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin. Zhongguo Yao Li Xue Bao (Acta Pharmacol Sin). 1995;16:333–337
  8. Zhao CT, Yang CZ, Shao XF, Xiong DS, Xu YF, Qi J, et al. Preliminary study on the role of protein kinase C in the multidurg resistance phenotype of K562/A02. Zhonghua Xue Ye Xue Za Zhi. 1998;19:261–262
  9. Tan Y, Zhao C, Yang C. Identification of unknown genes involved in multidrug resistance in K562/A02 cells by cDNA microarray. Acta Acad Med Sinica. 2001;23:272
  10. Meyers MB, Biedler JL. Increased synthesis of a low molecular weight protein in vincristine-resistant cells. Biochem Biophys Res Commun. 1981;99:228–235
  11. Koch G, Smith M, Twentyman P, Wright K. Identification of a novel calcium-binding protein (CP22) in multidrug-resistant murine and hamster cells. FEBS Lett. 1986;195:275–279
  12. Meyers MB. Sorcin a calcium-binding protein overproduced in many multidrug-resistant cells. In:  Smith VL,  Dedman JR editor. Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton: CRC Press; 1990;p. 159–171
  13. Wang SL, Tam MF, Ho YS, Pai SH, Kao MC. Isolation and molecular cloning of human sorcin a calcium-binding protein in vincristine-resistant HOB1 lymphoma cells. Biochim Biophys Acta. 1995;1260:285–293
  14. Beyer-Sehlmeyer G, Hiddemann W, Wormann B, Bertram J. Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin. Eur J Cancer. 1999;35:1735–1742
  15. Parekh HK, Deng HB, Choudhary K, Houser SR, Simpkins H. Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochem Pharmacol. 2002;63:1149–1158
  16. Tan Y, Li G, Zhao C, Wang J, Zhao H, Xue Y, et al. Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leuk Res. 2003;27:125–131
  17. Hartree EF. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem. 1972;48:422–427
  18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63
  19. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomics to mechanism. Oncogene. 2003;22:7468–7485
  20. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev. 2003;55:3–29
  21. Baer MR, George SL, Dodge RK, O’Loughlin KL, Minderman H, Caligiuri MA, et al. Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720. Blood. 2002;100:1224–1232
  22. Greenberg PL, Lee SJ, Advani R, Tallman MS, Sikic BI, Letendre L, et al. Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995). J Clin Oncol. 2004;22:1078–1086
  23. Hamada H, Okochi E, Oh-hara T, Tsuruo T. Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies. Cancer Res. 1988;48:3173–3178
  24. Meyers MB. A 22kDa calcium-binding protein, sorcin, is encodedby amplified genes in multidrug-resistant cells. In:  Heizman CW editors. Novel calcium-binding protein: fundamentals and clinical implications. Heidelberg: Springer; 1991;p. 385–399
  25. Lee WP. Purification, cDNA cloning, and expression of human sorcin in vincristine-resistant HOB1 lymphoma cell lines. Arch Biochem Biophys. 1996;325:217–226
  26. Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S, et al. Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun. 1991;3:181–189

PII: S0145-2126(05)00331-0

doi: 10.1016/j.leukres.2005.08.024

Leukemia Research
Volume 30, Issue 4 , Pages 469-476 , April 2006

Article Tools

* Image Usage & Resolution